Erste Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,000
Closed -$571K 662
2025
Q3
$571K Hold
17,000
0.01% 463
2025
Q2
$465K Hold
17,000
﹤0.01% 643
2025
Q1
$512K Hold
17,000
0.01% 430
2024
Q4
$682K Hold
17,000
0.01% 415
2024
Q3
$574K Hold
17,000
0.01% 424
2024
Q2
$374K Hold
17,000
0.01% 442
2024
Q1
$369K Hold
17,000
0.01% 450
2023
Q4
$487K Hold
17,000
0.01% 426
2023
Q3
$389K Hold
17,000
0.01% 428
2023
Q2
$440K Hold
17,000
0.01% 429
2023
Q1
$350K Hold
17,000
0.01% 459
2022
Q4
$410K Hold
17,000
0.01% 441
2022
Q3
$283K Hold
17,000
0.01% 474
2022
Q2
$339K Hold
17,000
0.01% 467
2022
Q1
$489K Hold
17,000
0.01% 438
2021
Q4
$664K Hold
17,000
0.01% 402
2021
Q3
$769K Hold
17,000
0.02% 362
2021
Q2
$702K Hold
17,000
0.01% 377
2021
Q1
$841K Hold
17,000
0.02% 343
2020
Q4
$833K Buy
+17,000
New +$788K 0.02% 352

Other funds holding VCYT

Erste Asset Management's VCYT Position: Q4 2025 in Review

Erste Asset Management sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 17,000 shares — an estimated $571K sold.

Erste Asset Management first reported a position in VCYT in Q4 2020 and held it in 20 quarters. The position peaked at $841K in Q1 2021. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Erste Asset Management reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Erste Asset Management sold 17,000 Veracyte shares in Q4 2025, an estimated $571K.
  • Erste Asset Management first reported a position in Veracyte in Q4 2020 and held it in 20 quarters.
  • Erste Asset Management's Veracyte position peaked at $841K in Q1 2021.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Erste Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.